Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2021 | 09-2021 | 06-2021 | 03-2021 | 12-2020 | |
| Sales | 333 | 153 | 3,480 | 685 | 3,786 |
| Gross Profit | 333 | 153 | 3,480 | 685 | 3,786 |
| Operating Expenses | 20,673 | 20,977 | 16,920 | 17,324 | 28,566 |
| Operating Income | -20,340 | -20,824 | -13,440 | -16,639 | -24,780 |
| Other Income | 192 | 145 | 67 | 101 | 1,941 |
| Pre-tax Income | -20,148 | -20,679 | -13,373 | -16,538 | -22,839 |
| Income Tax | N/A | -227 | N/A | N/A | -939 |
| Net Income Continuous | -20,148 | -20,452 | -13,373 | -16,538 | -21,900 |
| Net Income | $-20,148 | $-20,452 | $-13,373 | $-16,538 | $-21,900 |
| EPS Basic Total Ops | -0.43 | -0.45 | -0.34 | -0.42 | -0.43 |
| EPS Basic Continuous Ops | -0.44 | -0.45 | -0.34 | -0.42 | -0.43 |
| EPS Diluted Total Ops | -0.43 | -0.45 | -0.34 | -0.42 | -0.43 |
| EPS Diluted Continuous Ops | -0.44 | -0.45 | -0.34 | -0.42 | -0.43 |
| EBITDA(a) | $-15,865 | $-23,306 | $-12,801 | $-15,912 | $-6,332 |